site map - BioXell

about us History •Milestones Team •Management •Board of Directors •Scientific Advisory Board Strategy Locations Careers •Current opportunities Corporate fact sheet	therapeutic focus Urology •Benign Prostatic Hyperplasia •Overactive Bladder •Male Infertility Inflammation •Sepsis •Inflammatory Bowel Disease •Post-Surgical Adhesions Pain Other therapeutic areas •Secondary Hyperparathyroidism •Osteoporosis	product pipeline Development pipeline •Urology Elocalcitol in BPH Elocalcitol in OAB Elocalcitol in male infertility •Inflammatory diseases TREM-1 in Sepsis BXL746 in Post-Surgical Adhesion •Pain MNAC13 in Pain •Other therapeutic areas BXL093 in Osteoporosis Discovery programs
technology VD3 platform TREM platform Anti-TrkA Scientific publications •2007 •2006 •2005 •2004 •2003 •2002 •2001 •2000 •1999 •1998	partnering Partnering Opportunities Collaborations	investors Corporate profile •Corporate fact sheet Share price Analyst coverage Annual shareholders meeting Reports & presentations E-mail alerts IR calendar & events Corporate governance Contact
media Press Releases •2008 •2007 •2006 •2005 •2004 •2003 •2002 Clippings FAQs Media Contacts